BETASERC

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey

Active ingredients

The drug BETASERC contains one active pharmaceutical ingredient (API):

1 Betahistine dihydrochloride UNII 49K58SMZ7U - BETAHISTINE HYDROCHLORIDE

Betahistine dihydrochloride is a histamine-like drug in which pharmacological activity can be attributed to a specific effects and/or more direct influences on recovery mechanisms the vestibular nuclei. It has weak agonist activity at histamine H1 receptors and moderate antagonist activity at H3 receptors. Betahistine may increase blood flow to the cochlear region as well as to the whole brain. Read about Betahistine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07CA01	Betahistine	N Nervous system → N07 Other nervous system drugs → N07C Antivertigo preparations → N07CA Antivertigo preparations
Discover more medicines within N07CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500214100032517, 500214100032617, 500214100032717
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2890-MEE-0617, 2958-MEE-0817, H6280713
Country: EE	Ravimiamet	Identifier(s): 1008436, 1008458, 1115727, 1115738, 1115749, 1620212, 1620223, 1620234, 1620245, 1620256, 1639414, 1639425, 1639436, 1827064, 1861781
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 017541, 020144, 038877
Country: FR	Base de données publique des médicaments	Identifier(s): 62972963
Country: HK	Department of Health Drug Office	Identifier(s): 37181, 38792, 51514
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-070232989, HR-H-722180471
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1006779, 1010240, 1015627, 1015628, 1015629, 1056093, 1063039, 1068855, 1070559, 1070749, 1072020, 1072624, 1072625, 1075305, 1075306, 1075307, 1075308, 1078434, 1079725, 1079726, 1085824, 1086394, 1086451, 1086738
Country: MT	Medicines Authority	Identifier(s): MA1507/02801, MA1507/02802, PI1438/01701A, PI1438/01702A, PI770/10601A, PI770/10602A, PI908/01401A, PI908/01402A
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 27413
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100145540, 100193935, 100194538, 100237680, 100254602, 100254654, 100255270, 100255317, 100255398, 100271871, 100279016, 100279022, 100283762, 100289285, 100294524, 100302614, 100306776, 100336168, 100338291, 100345204, 100349774, 100349863, 100377121, 100384635, 100385273, 100386338, 100393090, 100400104, 100406549, 100408910, 100413242, 100414945, 100418541, 100423536, 100423660, 100424381, 100425400, 100435321, 100447815, 100450506, 100452381, 100464682, 100468171
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68647001, W68647002, W68647003, W68647004, W68647005, W68852001, W68852002, W68853001, W68853002, W68853003, W68853004
Country: SG	Health Sciences Authority	Identifier(s): 11365P, 12235P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9253072
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699548014444, 8699820010058, 8699820010126, 8699820010140, 8699820010324, 8699820010331